Get started
Author

Gastón Copertari

Institution: Helios Salud
ORCID: 0009-0007-1893-5444
Observed ORCID: 0009-0007-1893-5444
OpenAlex ID: A5093119591
Effectiveness, safety, and patient-reported outcomes of treatment with bictegravir/emtricitabine/tenofovir alafenamide fixed dose combination in people living with HIV in Argentina: the BICTARG cohort
2024 · Diego Cecchini, Martín Brizuela, et al. · Revista Española de Quimioterapia · 5
Clinical and epidemiological characteristics of the 2022-2023 Mpox outbreak in Buenos Aires, Argentina.
2025 · Romina Mauas, María José Rolón, et al. · PubMed · 1
Descripción epidemiológica de los episodios de sífilis asistidos en una institución de la Ciudad de Buenos Aires durante el período 2008-2011
2023 · Fernando Mozún, Valeria Confalonieri, et al. · Actualizaciones en Sida e Infectología · 1
PDF
Long-term effectiveness of bictegravir/emtricitabine/tenofovir alafenamide in people with HIV and resistance-associated mutations
2026 · Cinthia S. Lamaizón, Diego Cecchini, et al. · AIDS
Long-term persistence, effectiveness, safety, and metabolic impact of bictegravir/emtricitabine/tenofovir alafenamide fixed-dose combination in people living with HIV in the BICTARG cohort
2026 · Diego Cecchini, Martín Brizuela, et al. · Revista Española de Quimioterapia
Bictegravir/emtricitabine/tenofovir alafenamide fixed-dose combination in advanced HIV disease.
2025 · Diego Cecchini, Carla Serrano, et al. · PubMed
Works count: 6
Citation count: 7
H-index: 1
I10-index:
Year
Topic
Type